Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
New On The Block Caribou Biosciences, Inc. (NASDAQ: CRBU ), a clinical-stage CRISPR genome-editing biopharmaceutical company, is exploring strategic alternatives to maximize stockholder value and plans to discontinue further development activities for its two allogeneic CAR-T cell therapy programs. The company has hire
Hexagon AB said it has signed a deal to acquire Rocscience from TA Associates and Rocscience founders for $535 million in a cash-free transaction.
Hexagon said it signed an agreement to buy Rocscience from TA Associates and Rocscience’s founders and management. The deal values Rocscience at an enterprise value of $535 million and is expected to close in the fourth quarter of 2026, subject to customary conditions.